49 related articles for article (PubMed ID: 18209725)
1. [Chinese consensus of allogeneic hematopoietic stem cell transplantation for hematological disease (Ⅲ) -acute graft-versus-host disease (2020)].
Stem Cell Application Group, Chinese Society of Hematology, Chinese Medical Association
Zhonghua Xue Ye Xue Za Zhi; 2020 Jul; 41(7):529-536. PubMed ID: 32549120
[No Abstract] [Full Text] [Related]
2. A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation-associated TMA.
Jodele S; Dandoy CE; Aguayo-Hiraldo P; Lane A; Teusink-Cross A; Sabulski A; Mizuno K; Laskin BL; Freedman J; Davies SM
Blood; 2024 Mar; 143(12):1112-1123. PubMed ID: 37946262
[TBL] [Abstract][Full Text] [Related]
3. Pathway-driven rare germline variants associated with transplant-associated thrombotic microangiopathy (TA-TMA).
Zhang Z; Hong W; Wu Q; Tsavachidis S; Li JR; Amos CI; Cheng C; Sartain SE; Afshar-Kharghan V; Dong JF; Bhatraju P; Martin PJ; Makar RS; Bendapudi PK; Li A
Thromb Res; 2023 May; 225():39-46. PubMed ID: 36948020
[TBL] [Abstract][Full Text] [Related]
4. Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research.
Schoettler ML; Carreras E; Cho B; Dandoy CE; Ho VT; Jodele S; Moissev I; Sanchez-Ortega I; Srivastava A; Atsuta Y; Carpenter P; Koreth J; Kroger N; Ljungman P; Page K; Popat U; Shaw BE; Sureda A; Soiffer R; Vasu S
Transplant Cell Ther; 2023 Mar; 29(3):151-163. PubMed ID: 36442770
[TBL] [Abstract][Full Text] [Related]
5. Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis.
Young JA; Pallas CR; Knovich MA
Bone Marrow Transplant; 2021 Aug; 56(8):1805-1817. PubMed ID: 33875812
[TBL] [Abstract][Full Text] [Related]
6. Acute kidney injury in the patient with cancer.
Rosner MH; Perazella MA
Kidney Res Clin Pract; 2019 Sep; 38(3):295-308. PubMed ID: 31284363
[TBL] [Abstract][Full Text] [Related]
7. Neurological adverse events post allogeneic hematopoietic cell transplantation: major determinants of morbidity and mortality.
Sakellari I; Gavriilaki E; Papagiannopoulos S; Gavriilaki M; Batsis I; Mallouri D; Vardi A; Constantinou V; Masmanidou M; Yannaki E; Smias C; Geroukis T; Kazis D; Kimiskidis V; Anagnostopoulos A
J Neurol; 2019 Aug; 266(8):1960-1972. PubMed ID: 31087160
[TBL] [Abstract][Full Text] [Related]
8. Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management.
Dvorak CC; Higham C; Shimano KA
Front Pediatr; 2019; 7():133. PubMed ID: 31024873
[TBL] [Abstract][Full Text] [Related]
9. Haptoglobin degradation product as a novel serum biomarker for hematopoietic stem cell transplant-associated thrombotic microangiopathy.
Schuh MP; Bennett MR; Lane A; Jodele S; Laskin BL; Devarajan P
Pediatr Nephrol; 2019 May; 34(5):865-871. PubMed ID: 30569313
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.
Khosla J; Yeh AC; Spitzer TR; Dey BR
Bone Marrow Transplant; 2018 Feb; 53(2):129-137. PubMed ID: 28967899
[TBL] [Abstract][Full Text] [Related]
11. Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation.
El-Bietar J; Warren M; Dandoy C; Myers KC; Lane A; Wallace G; Davies SM; Jodele S
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1994-2001. PubMed ID: 26150023
[TBL] [Abstract][Full Text] [Related]
12. The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy.
Balassa K; Andrikovics H; Remenyi P; Batai A; Bors A; Kiss KP; Szilvasi A; Rajczy K; Inotai D; Gopcsa L; Lengyel L; Barta A; Reti M; Tordai A; Masszi T
Bone Marrow Transplant; 2015 Oct; 50(10):1321-5. PubMed ID: 26146809
[TBL] [Abstract][Full Text] [Related]
13. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.
Jodele S; Laskin BL; Dandoy CE; Myers KC; El-Bietar J; Davies SM; Goebel J; Dixon BP
Blood Rev; 2015 May; 29(3):191-204. PubMed ID: 25483393
[TBL] [Abstract][Full Text] [Related]
14. Fragmented Red Cell as a Possible Favorable Prognostic Marker of Hematopoietic Stem Cell Transplantation Associated Thrombotic Microangiopathy.
Jekarl DW; Kim Y; Lim J; Kim M; Han K; Cho B; Kim HK; Min WS; Min CK
J Clin Lab Anal; 2015 Nov; 29(6):444-50. PubMed ID: 25385174
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.
Labrador J; López-Corral L; López-Godino O; Vázquez L; Cabrero-Calvo M; Pérez-López R; Díez-Campelo M; Sánchez-Guijo F; Pérez-López E; Guerrero C; Alberca I; Del Cañizo MC; Pérez-Simón JA; González-Porras JR; Caballero D
Bone Marrow Transplant; 2014 May; 49(5):684-90. PubMed ID: 24566710
[TBL] [Abstract][Full Text] [Related]
16. Early coagulation disorder after allogeneic stem cell transplantation is a strong prognostic factor for transplantation-related mortality, and intervention with recombinant human thrombomodulin improves the outcome: a single-center experience.
Nagasawa M; Ohkawa T; Endo A; Mitsuiki N; Ono T; Aoki Y; Isoda T; Tomizawa D; Takagi M; Kajiwara M; Morio T; Mizutani S
Int J Hematol; 2013 Nov; 98(5):533-42. PubMed ID: 24081926
[TBL] [Abstract][Full Text] [Related]
17. Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?
Jodele S; Laskin BL; Goebel J; Khoury JC; Pinkard SL; Carey PM; Davies SM
Transfusion; 2013 Mar; 53(3):661-7. PubMed ID: 22804695
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Cho BS; Min CK; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim Y; Kim DW; Lee JW; Min WS; Kim CC
Bone Marrow Transplant; 2008 May; 41(9):813-20. PubMed ID: 18209725
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
